Collapsing the Tumor Ecosystem: Preventing Adaptive Response to Treatment by Inhibiting Transcription

Alessandro Carugo1, Giulio F Draetta2

  • 1Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Discovery
|January 10, 2018
PubMed

Insights

Cancer drug resistance emerges from genetic changes. A dual CDK7/12 inhibitor, THZ1, effectively targets drug-tolerant cells by disrupting their transcriptional machinery, preventing survival during therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Cancer therapies often trigger adaptive resistance through epigenetic and genetic events.
  • Tumor heterogeneity allows a dominant cell population to survive initial treatment.

Purpose of the Study:

  • To investigate novel therapeutic strategies targeting drug-tolerant cancer cells.
  • To identify vulnerabilities in cancer cell adaptation mechanisms.

Main Methods:

  • Utilized THZ1, a dual Cyclin-Dependent Kinase (CDK) 7/12 inhibitor.
  • Assessed the impact of THZ1 on transcriptional machinery in drug-tolerant cells.

Main Results:

  • Drug-tolerant cancer cells demonstrated sensitivity to THZ1.
  • THZ1 impaired the transcriptional machinery, hindering cellular adaptation.
  • Inhibition of transcriptional rewiring prevented therapeutic resistance.

Conclusions:

  • THZ1 represents a promising therapeutic agent against drug-tolerant cancer cells.
  • Targeting transcriptional regulation is a viable strategy to overcome cancer treatment resistance.

Related Concept Videos

What is an Ecosystem?01:17

What is an Ecosystem?

Overview
47.4K
The Soil Ecosystem02:23

The Soil Ecosystem

Plants obtain inorganic minerals and water from the soil, which acts as a natural medium for land plants. The composition and quality of soil depend not only on the chemical constituents but also on the presence of living organisms. In general, soils contain three major components:
25.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K